High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets.
Saved in:
| Title: | High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets. |
|---|---|
| Authors: | Mertens WC; Department of Medical Oncology, London Regional Cancer Centre, Ontario, Canada., Banerjee D, al-Mutter N, Stitt L, Bramwell VH, Lala PK |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 1995 Nov; Vol. 41 (5), pp. 271-9. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 8536272 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mertens+WC%22">Mertens WC</searchLink>; Department of Medical Oncology, London Regional Cancer Centre, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Banerjee+D%22">Banerjee D</searchLink><br /><searchLink fieldCode="AU" term="%22al-Mutter+N%22">al-Mutter N</searchLink><br /><searchLink fieldCode="AU" term="%22Stitt+L%22">Stitt L</searchLink><br /><searchLink fieldCode="AU" term="%22Bramwell+VH%22">Bramwell VH</searchLink><br /><searchLink fieldCode="AU" term="%22Lala+PK%22">Lala PK</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 1995 Nov; Vol. 41 (5), pp. 271-9. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0340-7004 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=8536272 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/BF01517214 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 271 Titles: – TitleFull: High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mertens WC – PersonEntity: Name: NameFull: Banerjee D – PersonEntity: Name: NameFull: al-Mutter N – PersonEntity: Name: NameFull: Stitt L – PersonEntity: Name: NameFull: Bramwell VH – PersonEntity: Name: NameFull: Lala PK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 1995 Nov Type: published Y: 1995 Identifiers: – Type: issn-print Value: 0340-7004 Numbering: – Type: volume Value: 41 – Type: issue Value: 5 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |